Novavax Inc vs Wipro Limited — how do they compare? Novavax Inc trades at $8.08 (market cap $1.30B), while Wipro Limited trades at $1.83 (market cap $18.49B). The key difference: Wipro Limited is far larger — about 14.2× Novavax Inc's market cap, and Wipro Limited pays a 4.68% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | WIT | |
|---|---|---|
Market Cap | $1.30B | $18.49B |
Sector | Health | Technology |
52-Week High | $11.19 | $3.06 |
52-Week Low | $6.22 | $1.82 |
Enterprise Value | $800.50M | $16.42B |
Dividend Yield | — | 4.68% |
Signals from Pluang's Aura AI — not financial advice
Novavax (NVAX) trades at $8.08, down 1.64% on the day, with a bearish technical signal but strong recent earnings beats. The company reported $1.12B revenue in 2025 with a net income of $440.30M, though 2026 projections show a return to losses. Analyst consensus is bullish with a $14.00 price target, but negative shareholder equity and cash flow concerns persist.
Outlook remains mixed: strong valuation ratios and analyst support suggest upside potential, but negative cash flows, high liabilities, and projected 2026 losses pose significant risks. Investor sentiment is cautious amid recent stock declines and shareholder dissent highlighted in recent news.
No Aura AI signal available yet.
Trailing returns across standard periods
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →Wipro is a leading global IT services provider, with 175,000 employees. Based in Bengaluru, this India IT services firm leverages its offshore outsourcing model to derive over half of its revenue (57%) from North America. The company offers traditional IT services offerings: consulting, managed services, and cloud infrastructure services as well as business process outsourcing as a service.
Read more on WIT →